Xiangyu Medical Co. Ltd. A Working Capital to Net Assets Ratio
Xiangyu Medical Co. Ltd. A working capital to net assets ratio. Xiangyu Medical Co. Ltd. A (688626) has a Working Capital to Net Assets ratio of 13.1% as of September 2025. Working capital of CN¥266.92 Million (current assets of CN¥1.31 Billion minus current liabilities of CN¥1.04 Billion) is measured against net assets of CN¥2.04 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible equity quality of Xiangyu Medical Co. Ltd. A to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Xiangyu Medical Co. Ltd. A (2017–2024)
Working capital to net assets ratio of Xiangyu Medical Co. Ltd. A from 2017 to 2024. This chart shows how Xiangyu Medical Co. Ltd. A's Working Capital to Net Assets ratio has evolved across 8 annual periods from 2017 to 2024. As of September 2025, the ratio stands at 13.1%, reflecting working capital of CN¥266.92 Million against net assets of CN¥2.04 Billion CNY. See how many days can Xiangyu Medical Co. Ltd. A fund operations to measure how many days the company can operate on defensive assets alone.
Xiangyu Medical Co. Ltd. A Working Capital to Net Assets Ratio by Year (2017–2024)
Xiangyu Medical Co. Ltd. A working capital to net assets ratio by year from 2017 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Xiangyu Medical Co. Ltd. A from 2017 to 2024, covering 8 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Xiangyu Medical Co. Ltd. A asset portfolio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 19.8% | CN¥407.00 Million | CN¥2.05 Billion | CN¥1.14 Billion | CN¥734.71 Million | ▼ -19.2 pp |
| 2023 | 39.0% | CN¥822.21 Million | CN¥2.11 Billion | CN¥1.19 Billion | CN¥372.14 Million | ▼ -28.9 pp |
| 2022 | 67.9% | CN¥1.32 Billion | CN¥1.94 Billion | CN¥1.67 Billion | CN¥351.80 Million | ▼ -11.0 pp |
| 2021 | 78.9% | CN¥1.54 Billion | CN¥1.95 Billion | CN¥1.72 Billion | CN¥181.42 Million | ▲ +15.5 pp |
| 2020 | 63.4% | CN¥471.38 Million | CN¥743.29 Million | CN¥671.39 Million | CN¥200.01 Million | ▼ -10.3 pp |
| 2019 | 73.7% | CN¥403.61 Million | CN¥547.28 Million | CN¥548.67 Million | CN¥145.05 Million | ▲ +4.6 pp |
| 2018 | 69.1% | CN¥286.67 Million | CN¥414.81 Million | CN¥411.09 Million | CN¥124.43 Million | ▲ +86.9 pp |
| 2017 | -17.8% | CN¥-17.63 Million | CN¥99.09 Million | CN¥261.13 Million | CN¥278.75 Million | — |